drug

ABBV-1162

1 story · latest Sep 25, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by AbbVie

Timeline

AbbVie registers first-in-human Phase 1 trial for oral ABBV-1162

Sep 25Weekly roundup, 2 itemsABBV-1162 AbbVieUpdated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.